Public Health | May 06, 2022
Survey highlights people living with Lupus report at least one major organ affected by the disease
Survey findings released in advance of World Lupus Day on May 10
Survey findings released in advance of World Lupus Day on May 10
The companies expect to complete the submission of the NDA for treatment of MDD in the second half of 2022; associated filing for postpartum depression is anticipated in the first half of 2023
Secretary, Department of Pharmaceuticals and Union Health Secretary Chair a Panel Discussion on the theme 'Indian Pharma Vision 2047'
Tardive dyskinesia (TD) is a movement disorder that is characterized by uncontrollable, abnormal and repetitive movements of the face, torso and/or other body parts, which may be disruptive and negatively impact patients
The survey indicates that 30% of people are still feeling depressed or hopeless on a few days as against GOQii’s last year survey on mental Health where 43% of Indians were depressed
Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and speciality products
Augnito in association with Japanese company Fujifilm enables voice recognition within their radiology information system platform
The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe
The company claims that this is the first time a mental wellness start-up has gone phygital in a Tier 2 city
The recently released WHO guideline on hypertension treatment (2021), recommends that patients with stable blood pressure can be asked to visit clinics at 3-6 month intervals as an important strategy to improve hypertension control
Subscribe To Our Newsletter & Stay Updated
